206 related articles for article (PubMed ID: 22302662)
1. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Neath SX; Landsberg J; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Christenson RH; Potocki M; McCord J; Terracciano G; Hartmann O; Bergmann A; Morgenthaler NG; Anker SD
Eur J Heart Fail; 2012 Mar; 14(3):278-86. PubMed ID: 22302662
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
[TBL] [Abstract][Full Text] [Related]
3. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
4. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia.
Wussler D; Kozhuharov N; Tavares Oliveira M; Bossa A; Sabti Z; Nowak A; Murray K; du Fay de Lavallaz J; Badertscher P; Twerenbold R; Shrestha S; Flores D; Nestelberger T; Walter J; Boeddinghaus J; Zimmermann T; Koechlin L; von Eckardstein A; Breidthardt T; Mueller C
Clin Chem; 2019 Dec; 65(12):1532-1542. PubMed ID: 31615771
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.
Aouifi A; Piriou V; Bastien O; Blanc P; Bouvier H; Evans R; Célard M; Vandenesch F; Rousson R; Lehot JJ
Crit Care Med; 2000 Sep; 28(9):3171-6. PubMed ID: 11008977
[TBL] [Abstract][Full Text] [Related]
8. Personalized CHF treatment: PCT to guide therapy in heart failure patients.
Lee NS; Daniels LB
Int J Cardiol; 2014 Sep; 176(2):307-8. PubMed ID: 25115245
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic properties of procalcitonin in patients with acute dyspnea: Data from the ACE 2 Study.
Berge K; Lyngbakken MN; Einvik G; Winther JA; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2018 Sep; 59():62-68. PubMed ID: 30028971
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin in heart failure: hic et nunc.
Cvetinovic N; Isakovic AM; Lainscak M; Dungen HD; Nikolic NM; Loncar G
Biomark Med; 2017 Oct; 11(10):893-903. PubMed ID: 28976777
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin and long-term prognosis after an admission for acute heart failure.
Villanueva MP; Mollar A; Palau P; Carratalá A; Núñez E; Santas E; Bodí V; Chorro FJ; Miñana G; Blasco ML; Sanchis J; Núñez J
Eur J Intern Med; 2015 Jan; 26(1):42-8. PubMed ID: 25592074
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18.
Möckel M; Slagman A; Vollert JO; Ebmeyer S; Wiemer JC; Searle J; Giannitsis E; Kellum JA; Maisel A
Biomarkers; 2018 Feb; 23(1):97-103. PubMed ID: 29264937
[TBL] [Abstract][Full Text] [Related]
13. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
[TBL] [Abstract][Full Text] [Related]
14. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.
Pfister R; Kochanek M; Leygeber T; Brun-Buisson C; Cuquemelle E; Machado MB; Piacentini E; Hammond NE; Ingram PR; Michels G
Crit Care; 2014 Mar; 18(2):R44. PubMed ID: 24612487
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases.
Wang W; Zhang X; Ge N; Liu J; Yuan H; Zhang P; Liu W; Wen D
Crit Care; 2014 Jan; 18(1):R4. PubMed ID: 24393388
[TBL] [Abstract][Full Text] [Related]
17. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM
Crit Care; 2011; 15(2):R88. PubMed ID: 21385367
[TBL] [Abstract][Full Text] [Related]
18. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
